Ophthalmology and Optometry articles for Sun Yat-sen University (SYSU), China

Time frame: 1 March 2024 - 28 February 2025

View topic

Count: 16

Article ‘Count’ for Ophthalmology and Optometry.

Journal Count Share
1 0.71
Achieving Ultra‐Broadband Sunlight‐Like Emission in Single‐Phase Phosphors: The Interplay of Structure and Luminescence 0.71
1 1.00
Characterization and Role of Glucagon-Like Peptide 1 Receptor in the Lacrimal Gland 1.00
1 0.69
Single‐Grain High‐Efficiency Full‐Visible‐Spectrum White Emitters 0.69
1 0.11
Realizing Stable Luminescence in Antimony Doped Hybrid Tin(IV) Chloride toward Full Spectrum WLED and Anticounterfeiting Applications 0.11
1 0.43
Naked-Eye 3-Dimensional Vision Training for Myopia Control 0.43
1 0.69
Three vs 6 Cycles of Chemotherapy for High-Risk Retinoblastoma 0.69
1 1.00
The transcription factor CREB regulates epithelial-mesenchymal transition of lens epithelial cells by phosphorylation-dependent and phosphorylation-independent mechanisms 1.00
3 1.65
Endothelial protein C receptor promotes retinal neovascularization through heme catabolism 0.10
Photoreceptor metabolic window unveils eye–body interactions 0.67
Cost-effectiveness and cost-utility of a digital technology-driven hierarchical healthcare screening pattern in China 0.89
1 0.03
Integrated image-based deep learning and language models for primary diabetes care 0.03
5 2.49
Real-World Evidence on Digital Therapeutics in Pediatric Amblyopia: Insights into Rapid Axial Elongation Risk 1.00
Behavioral Intervention with Eye-Use Monitoring to Delay Myopia Onset and Progression in Children: A Cluster Randomized Trial 0.18
Plasma metabolomics identifies key metabolites and improves prediction of diabetic retinopathy: development and validation across multi-national cohorts 0.60
Repeated Low-Level Red-Light Therapy for Myopia Control in High Myopia Children and Adolescents: A Randomized Clinical Trial 0.09
Myopia Control Effect of Repeated Low-Level Red-Light Therapy Combined with Orthokeratology: A Multicenter Randomized Controlled Trial 0.62

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.